Literature DB >> 7626362

Head-up tilt testing: the balance of evidence.

C A Morillo, K A Ellenbogen, G J Klein.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7626362      PMCID： PMC483925          DOI： 10.1136/hrt.73.6.583

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  9 in total

1.  Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope.

Authors:  J S Sra; V S Murthy; M R Jazayeri; Y H Shen; P J Troup; B Avitall; M Akhtar
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

2.  Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin.

Authors:  B P Grubb; P Temesy-Armos; H Hahn; L Elliott
Journal:  Am J Med       Date:  1991-01       Impact factor: 4.965

3.  Coronary perforation after excimer laser coronary angioplasty: the Excimer Laser Coronary Angioplasty Registry experience.

Authors:  D R Holmes; G S Reeder; Z M Ghazzal; J F Bresnahan; S B King; M B Leon; F Litvack
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

4.  NHLBI funding policies. Enhancing stability, predictability, and cost control.

Authors:  C Lenfant
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

5.  Head-up tilt testing. The balance of evidence.

Authors:  A D Hargreaves; O el Hag; N A Boon
Journal:  Br Heart J       Date:  1994-09

6.  A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope.

Authors:  M Brignole; C Menozzi; L Gianfranchi; G Lolli; N Bottoni; D Oddone
Journal:  Am J Cardiol       Date:  1992-08-01       Impact factor: 2.778

7.  Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing.

Authors:  J S Sra; A J Anderson; S H Sheikh; B Avitall; P J Tchou; P J Troup; C J Gilbert; M Akhtar; M R Jazayeri
Journal:  Ann Intern Med       Date:  1991-06-15       Impact factor: 25.391

8.  Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia.

Authors:  S Milstein; J Buetikofer; A Dunnigan; D G Benditt; C Gornick; W J Reyes
Journal:  Am J Cardiol       Date:  1990-06-01       Impact factor: 2.778

9.  A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt.

Authors:  C A Morillo; J W Leitch; R Yee; G J Klein
Journal:  J Am Coll Cardiol       Date:  1993-12       Impact factor: 24.094
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.